Avon Products Inc. today officially announced a breakthrough anti-aging sun care collection — ANEW Solar Advance with RepairShield™ Technology. The research behind this revolutionary line was unveiled at the American Academy of Dermatology’s 69th annual meeting. The ANEW Solar Advance anti-aging sun care line not only provides superior protection against the sun’s damaging rays with photostable broad-spectrum UVA/UVB protection, but is also designed to repair skin cell sun damage.* Patented RepairShield Technology™ is designed to protect skin by stimulating its natural antioxidant defense system to fight free radicals and to repair by activating skin’s natural repair process.
To view Multimedia News Release, go to http://multivu.prnewswire.com/mnr/avon/42980/
Avon celebrated the brand’s latest innovation, ANEW Clinical Pro Line Eraser Treatment, with flash mobs coast to coast in five cities, including New York, Chicago, Atlanta, Dallas and Los Angeles. Professional ballroom dancer Karina Smirnoff led the moves and wowed the crowd in Los Angeles. Avon Representatives in all cities joined in on the flash mobs and distributed tens of thousands of samples of ANEW Clinical Pro Line Eraser Treatment, which launches this month across the country.
“I can never turn down an opportunity to dance—especially when it’s celebrating such an exciting new innovation like Pro Line Eraser Treatment,” says Smirnoff. “I’m so thrilled to be a part of this big moment for Avon and spending time with the Representatives and fans.”
To view Multimedia News Release, go to http://www.multivu.com/mnr/52897-avon-anew-clinical-pro-line-eraser-treatment-skincare-dermatology
In recognition of Melanoma Monday® and National Melanoma/Skin Cancer Detection & Prevention MonthTM, MELA Sciences, Inc. (NASDAQ: MELA) visited the NASDAQ MarketSite in Times Square today to ring the Opening Bell and sponsor free skin cancer checks.
One American dies every hour from melanoma, the most deadly skin cancer. MELA Sciences, Inc. is the pioneer company behind MelaFind®, the first and only FDA-approved diagnostic tool that helps dermatologists detect melanoma at its most curable stage. MelaFind® was approved by the U.S. Food & Drug Administration (FDA) in Fall 2011, and since then has strategically rolled out the technology to dermatology practices across the country.
To view Multimedia News Release, go to http://www.multivu.com/mnr/61584-mela-sciences-rings-opening-bell-awareness-melanoma-detection-prevention
Everyone loses hair, every single day. We see strands everywhere – the shower, in the brush, on our pillows. Thinning in women usually means a reduction in volume as well as less physical hairs on our head. As strands diminish in number, there is a lack of density.
The American Hair Loss Association estimates that women make up roughly 40 percent of Americans experiencing thinning hair and the majority of women will experience some thinning by midlife – putting it right up with weight gain, dry skin and wrinkles.
It is completely natural for hair to thin over time. According to the American Academy of Dermatology, we normally shed about 100 hairs a day. So, while 85-to-95 percent of the hair on your head is growing, the other 5-to-15 percent is in a resting stage. After “resting,” this hair falls out — often while you’re brushing or shampooing it — and is replaced by new growth.
To view the Multimedia News Release, go to: http://www.multivu.com/players/English/7361651-biota-botanicals-age-related-thinning-hair-care-for-women/
Cutanea Life Sciences, Inc. (CLS), an emerging U.S. prescription product development company, formally unveiled its new digital presence, www.cutanea.com, to the dermatology community in conjunction with this winter’s annual gathering of dermatologists from the U.S and around the world. CLS has a stream of innovative product candidates in different stages of development that cover an array of skin conditions, including acne, rosacea, psoriasis and warts caused by human papillomavirus (HPV).
CLS’s new digital presence demonstrates the company’s intent to change the way that customers think about a valued dermatology partner. CLS believes that it can make an impact in the current state of dermatology practice through its commitment to focus on unmet and underserved patient needs. In turn this will help medical professionals optimize their practice time through CLS products and services.
To view the multimedia release go to:
http://www.multivu.com/players/English/7743651-cutanea-life-sciences-dermatology/
